MEDIORG — Medicamen Organics Balance Sheet
0.000.00%
- IN₹322.34m
- IN₹453.98m
- IN₹381.88m
- 54
- 88
- 24
- 60
Annual balance sheet for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 9.01 | 4.45 | 5.59 | 5.53 | 41.3 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 111 | 99.6 | 137 | 191 | 275 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 149 | 156 | 206 | 273 | 454 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 105 | 103 | 98.1 | 105 | 123 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 255 | 261 | 307 | 384 | 592 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 165 | 171 | 209 | 216 | 272 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 182 | 187 | 220 | 232 | 291 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 73.6 | 74.7 | 86.9 | 153 | 301 |
| Total Liabilities & Shareholders' Equity | 255 | 261 | 307 | 384 | 592 |
| Total Common Shares Outstanding |